YU30292A - Nova aktivna jedinejnja - Google Patents

Nova aktivna jedinejnja

Info

Publication number
YU30292A
YU30292A YU30292A YU30292A YU30292A YU 30292 A YU30292 A YU 30292A YU 30292 A YU30292 A YU 30292A YU 30292 A YU30292 A YU 30292A YU 30292 A YU30292 A YU 30292A
Authority
YU
Yugoslavia
Prior art keywords
active unit
new active
new
unit
formula
Prior art date
Application number
YU30292A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
C. Briving
M. Elebring
S. Carlsson
R. Carter
T. Kuhler
P. Nordberg
I. Starke
A. Svensson
Original Assignee
Aktiebolagen Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolagen Astra filed Critical Aktiebolagen Astra
Publication of YU30292A publication Critical patent/YU30292A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU30292A 1991-03-27 1992-03-26 Nova aktivna jedinejnja YU30292A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100920A SE9100920D0 (sv) 1991-03-27 1991-03-27 New active compounds

Publications (1)

Publication Number Publication Date
YU30292A true YU30292A (sh) 1995-01-31

Family

ID=20382295

Family Applications (1)

Application Number Title Priority Date Filing Date
YU30292A YU30292A (sh) 1991-03-27 1992-03-26 Nova aktivna jedinejnja

Country Status (30)

Country Link
US (1) US5439917A (enExample)
EP (2) EP0580616A1 (enExample)
JP (1) JP3122792B2 (enExample)
CN (1) CN1067892A (enExample)
AP (1) AP309A (enExample)
AT (1) ATE175672T1 (enExample)
AU (1) AU655634B2 (enExample)
BG (1) BG98124A (enExample)
CA (1) CA2106880A1 (enExample)
DE (1) DE69228142T2 (enExample)
DK (1) DK0509974T3 (enExample)
ES (1) ES2129039T3 (enExample)
FI (1) FI934203L (enExample)
GR (1) GR3029834T3 (enExample)
HU (1) HUT65948A (enExample)
IE (1) IE920915A1 (enExample)
IL (1) IL101347A0 (enExample)
IS (1) IS3827A (enExample)
JO (1) JO1704B1 (enExample)
MA (1) MA22477A1 (enExample)
MX (1) MX9201324A (enExample)
NO (1) NO933425L (enExample)
NZ (1) NZ241943A (enExample)
SE (1) SE9100920D0 (enExample)
SK (1) SK103093A3 (enExample)
TN (1) TNSN92026A1 (enExample)
TW (1) TW198032B (enExample)
WO (1) WO1992017477A1 (enExample)
YU (1) YU30292A (enExample)
ZA (1) ZA921823B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2001047922A2 (en) 1999-12-24 2001-07-05 Aventis Pharma Limited Azaindoles
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
KR20040111445A (ko) * 2002-03-28 2004-12-31 에자이 가부시키가이샤 신경퇴행성 질환 치료용 ｃ─Ｊｕｎ Ｎ─말단 키나아제억제제로서의 ７─아자인돌
JP4634144B2 (ja) * 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
SI1606261T1 (sl) 2003-03-10 2010-03-31 Nycomed Gmbh Novi postopek za pripravo roflumilasta
US6981980B2 (en) 2003-03-19 2006-01-03 Phagia Technology Self-inflating intragastric volume-occupying device
US7612086B2 (en) 2003-05-16 2009-11-03 Eisai R & D Management Co. Ltd. JNK inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
GB0516156D0 (en) * 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds

Also Published As

Publication number Publication date
NO933425D0 (no) 1993-09-24
WO1992017477A1 (en) 1992-10-15
NZ241943A (en) 1993-12-23
MA22477A1 (fr) 1992-10-01
BG98124A (bg) 1994-11-15
FI934203A7 (fi) 1993-09-24
IS3827A (is) 1992-09-28
DE69228142T2 (de) 1999-07-22
JO1704B1 (en) 1992-12-15
NO933425L (no) 1993-10-25
TW198032B (enExample) 1993-01-11
DE69228142D1 (de) 1999-02-25
GR3029834T3 (en) 1999-06-30
FI934203A0 (fi) 1993-09-24
CA2106880A1 (en) 1992-09-28
DK0509974T3 (da) 1999-08-30
IE920915A1 (en) 1992-10-07
HU9302741D0 (en) 1993-12-28
EP0509974A1 (en) 1992-10-21
AU655634B2 (en) 1995-01-05
ES2129039T3 (es) 1999-06-01
SK103093A3 (en) 1994-08-10
CN1067892A (zh) 1993-01-13
ATE175672T1 (de) 1999-01-15
EP0509974B1 (en) 1999-01-13
JP3122792B2 (ja) 2001-01-09
AP309A (en) 1994-01-13
EP0580616A1 (en) 1994-02-02
TNSN92026A1 (fr) 1993-06-08
AU1426092A (en) 1992-11-02
IL101347A0 (en) 1992-11-15
AP9200369A0 (en) 1992-04-30
ZA921823B (en) 1992-11-25
US5439917A (en) 1995-08-08
HUT65948A (en) 1994-08-29
SE9100920D0 (sv) 1991-03-27
MX9201324A (es) 1992-10-01
JPH06506448A (ja) 1994-07-21
FI934203L (fi) 1993-09-24

Similar Documents

Publication Publication Date Title
YU30292A (sh) Nova aktivna jedinejnja
NO931695L (no) Nye 4-arylpiperaciner og 4-arylpiperidiner
FR2446822A1 (fr) 6-oxodecahydroquinoleines
ATE211139T1 (de) Tetrahydroimidazopyridoindoldione als cgmp spezifische pde hemmer
MY111201A (en) New imidazopyridines
FR2453145A1 (enExample)
FR2416222A1 (fr) Derives perfluoroalkyl-thioethyl-ether
IT1285770B1 (it) Composti corticoidei
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
FR2453175A1 (fr) Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)-indoles dextrogyres
FR2445834A1 (fr) Derives heterobicycliques de l'acide 7-acylamido-3-cephem-4-carboxylique insature, procedes de preparation de ceux-ci et utilisation en therapeutique
NO163957C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser.
FR2383185A1 (enExample)
FR2369259A1 (fr) Derives de 3,3-dichloro-2-azetidinone ayant une activite anti-inflammatoire
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
DE69132578D1 (de) Cephemderivate
FR2361351A1 (fr) Intermediaires de preparation d'homologues de somatostatine
GR1000887B (el) Νεα παραγωγα σπιροφουρανης.
FR2422651A1 (fr) Derives de pyrrolidinecarboxaldehyde et de piperidinecarboxaldehyde a usage therapeutique
FR2429778A1 (fr) Nouvelles n,n'-bis((n-cyano-n'-alcynyl)methanimidamidyl)-cystamines
AU1646588A (en) Protected cyclopantanols
NO981909L (no) Fungicide forbindelser (B)
FR2426046A1 (fr) Derive de tetrahydro-isoquinoleine, sa preparation et son application en therapeutique
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru
FR2361335A1 (fr) 4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol